This might indicate that the gene signature for irradiated patients does not work for non-irradiated patients and may be related to the fact that animal studies indicated limited survival advantages of CSF-1R inhibition alone in mouse glioma models [3,4,10]. This evidence concerns the gene CSF1R and central nervous system cancer.